- Home
- ALTS vs CTMX Comparison
ALTS vs CTMX Comparison
Compare ALTS & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTS
- CTMX
- Stock Information
- Founded
- ALTS 1976
- CTMX 2008
- Country
- ALTS United States
- CTMX United States
- Employees
- ALTS N/A
- CTMX N/A
- Industry
- ALTS
- CTMX Biotechnology: Pharmaceutical Preparations
- Sector
- ALTS
- CTMX Health Care
- Exchange
- ALTS NYSE
- CTMX Nasdaq
- Market Cap
- ALTS 72.7M
- CTMX 62.3M
- IPO Year
- ALTS N/A
- CTMX 2015
- Fundamental
- Price
- ALTS $4.09
- CTMX $0.59
- Analyst Decision
- ALTS
- CTMX Buy
- Analyst Count
- ALTS 0
- CTMX 6
- Target Price
- ALTS N/A
- CTMX $5.77
- AVG Volume (30 Days)
- ALTS 197.7K
- CTMX 3.5M
- Earning Date
- ALTS 05-02-2025
- CTMX 03-06-2025
- Dividend Yield
- ALTS N/A
- CTMX N/A
- EPS Growth
- ALTS N/A
- CTMX N/A
- EPS
- ALTS N/A
- CTMX 0.38
- Revenue
- ALTS $7,110,000.00
- CTMX $138,103,000.00
- Revenue This Year
- ALTS N/A
- CTMX N/A
- Revenue Next Year
- ALTS N/A
- CTMX N/A
- P/E Ratio
- ALTS N/A
- CTMX $1.55
- Revenue Growth
- ALTS N/A
- CTMX 36.45
- 52 Week Low
- ALTS $1.29
- CTMX $0.56
- 52 Week High
- ALTS $7.75
- CTMX $5.85
- Technical
- Relative Strength Index (RSI)
- ALTS 33.65
- CTMX 30.34
- Support Level
- ALTS $4.41
- CTMX $0.60
- Resistance Level
- ALTS $4.91
- CTMX $0.78
- Average True Range (ATR)
- ALTS 0.55
- CTMX 0.06
- MACD
- ALTS -0.23
- CTMX -0.00
- Stochastic Oscillator
- ALTS 1.12
- CTMX 13.69
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. It is providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment and safe-keeping of digital assets. The company product include ALT 5 Prime is an electronic over-the-counter trading platform and ALT 5 Pay crypto payment processor.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.